BridgeBio Pharma | 8-K: Current report
BridgeBio Pharma | 8-K: Current report
BridgeBio Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
BridgeBio Pharma | 8-K: BridgeBio Pharma Reports Second Quarter 2024 Financial Results and Business Update
BridgeBio Pharma | 8-K: Current report
BridgeBio Pharma | 8-K: Current report
BridgeBio Pharma | 8-K: Current report
BridgeBio Pharma | 8-K: BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update
BridgeBio Pharma | DEFA14A: Others
BridgeBio Pharma | DEF 14A: Definitive information statements
BridgeBio Pharma | 8-K: Current report
BridgeBio Pharma | 8-K: Current report
BridgeBio Pharma | 8-K: BridgeBio Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
BridgeBio Pharma | 8-K: Current report
BridgeBio Pharma | 8-K: Current report
BridgeBio Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
BridgeBio Pharma | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
BridgeBio Pharma | 8-K: BridgeBio Pharma Reports Third Quarter 2023 Financial Results and Business Update
BridgeBio Pharma | 8-K: Current report
BridgeBio Pharma | 8-K: BridgeBio Pharma Reports Second Quarter 2023 Financial Results and Business Update
No Data
No Data